ES2111580T3 - 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2111580T3
ES2111580T3 ES92106162T ES92106162T ES2111580T3 ES 2111580 T3 ES2111580 T3 ES 2111580T3 ES 92106162 T ES92106162 T ES 92106162T ES 92106162 T ES92106162 T ES 92106162T ES 2111580 T3 ES2111580 T3 ES 2111580T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
aryl
alkyler
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92106162T
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Lawrence Leo Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2111580T3 publication Critical patent/ES2111580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION ESTA RELACIONADA CON LOS COMPUESTOS CON LA FORMULA (I) EN DONDE R1 ES HIDROGENO, ALQUILO INFERIOR, ALQUENILO INFERIOR, ALQUINILO INFERIOR, ALQUILO INFERIOR DE AMINO, ALQUILO INFERIOR DE ALQUILAMINO, FORMILO, ALQUILCARBOXILO INFERIOR, ALQUILCARBOXILO INFERIOR DE AMINO O ALCOXICARBONILO INFERIOR; EL GRUPO -X-Y = ES SIENDO R2 Y R3 INDEPENDIENTEMENTE HIDROGENO O ALQUILO INFERIOR; W ES HIDROGENO, HALOGENO, HIDROXI, ALCOXI INFERIOR, ALCOXI INFERIOR DE ARILO O EN DONDE R4 ES HIDROGENO, ALQUILO INFERIOR O ALQUILO INFERIOR DE ARILO; R5 ES ALQUILO INFERIOR O ALQUILO INFERIOR DE ARILO; O ALTERNATIVAMENTE EL GRUPO COMO UN TODO ES SIENDO R6 HIDROGENO, ALQUILO INFERIOR, ARILO O ALQUILO INFERIOR DE ARILO; Y Z ES HIDROGENO, HALOGENO, ALQUILO INFERIOR, NITRO O AMINO; QUE SON UTILES PARA ALIVIAR VARIAS DISFUNCIONES DE MEMORIA TALES COMO LA ENFERMEDAD DE ALZHEIMER, COMO MODULADORES DE FUNCIONES NEUROTRANSMISORAS TALES COMO SEROTONERGICAS Y ADRENERGICAS, Y COMO TALES SON UTILES COMO ANTIDEPRESIVOS, ANSIOLITICOS, ANTIPSICOTICOS ATIPICOS, ANTIEMETICOS, Y PARA EL TRATAMIENTO DE DESORDENES DE LA PERSONALIDAD TALES COMO DESORDENES COMPULSIVOS OBSESIVOS.
ES92106162T 1991-04-17 1992-04-09 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2111580T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/688,964 US5177088A (en) 1991-04-17 1991-04-17 Substituted 3-(pyridinylamino)-indoles

Publications (1)

Publication Number Publication Date
ES2111580T3 true ES2111580T3 (es) 1998-03-16

Family

ID=24766519

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92106162T Expired - Lifetime ES2111580T3 (es) 1991-04-17 1992-04-09 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (25)

Country Link
US (1) US5177088A (es)
EP (1) EP0509402B1 (es)
JP (1) JP2617650B2 (es)
KR (1) KR100254027B1 (es)
AT (1) ATE161840T1 (es)
AU (1) AU655253B2 (es)
BG (1) BG61034B1 (es)
CA (1) CA2066332C (es)
CS (1) CS117192A3 (es)
DE (1) DE69223837T2 (es)
DK (1) DK0509402T3 (es)
ES (1) ES2111580T3 (es)
FI (1) FI105096B (es)
GR (1) GR3026317T3 (es)
HU (1) HU215113B (es)
IE (1) IE921235A1 (es)
IL (1) IL101599A (es)
MX (1) MX9201759A (es)
NO (1) NO180486C (es)
NZ (1) NZ242359A (es)
PL (1) PL168905B1 (es)
RO (1) RO109847B1 (es)
RU (1) RU2060254C1 (es)
TW (1) TW200477B (es)
ZA (1) ZA922807B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
DK0833820T3 (da) * 1995-06-06 2001-04-17 Aventis Pharma Inc Benzisoxazol- og indazolderivater som antipsykotiske midler
US5668154A (en) * 1995-06-06 1997-09-16 Hoechst Marion Roussel Inc. Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
KR20000062358A (ko) * 1996-12-27 2000-10-25 게리 디. 스트리트, 스티븐 엘. 네스비트 알츠하이머병 및 울병 치료용 n-(피리디닐아미노)이소인돌린
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
PT1216244E (pt) * 1999-09-14 2003-12-31 Aventis Pharma Inc Derivados de benzisoxazolil- piridoisoxazolil- e benztienil-fenoxi uteis como antagonistas d4
DE10029371A1 (de) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka
GB0217920D0 (en) * 2002-04-23 2002-09-11 Aventis Pharm Prod Inc Interleukin-4 Gene Expression inhibitors
ES2340180T3 (es) 2004-06-01 2010-05-31 F.Hoffmann-La Roche Ag 3-amino-1-arilpropil-indoles como inhibidores de reabsorcion de monoaminas.
JP2009517430A (ja) 2005-11-30 2009-04-30 エフ.ホフマン−ラ ロシュ アーゲー 3−アミノ−1−アリールプロピルインドール類及びアザ置換インドール類
ATE442368T1 (de) 2005-11-30 2009-09-15 Hoffmann La Roche 3-amino-2-arylpropylazaindole und anwendungen davon
EP2351737A1 (en) * 2005-11-30 2011-08-03 F. Hoffmann-La Roche AG 3-Amino-1-arylpropyl indoles and aza-substituted indoles
EP2230238B1 (en) * 2008-01-04 2013-12-11 LG Life Sciences Ltd. Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049779B1 (en) * 1980-09-18 1984-10-31 Asahi Kasei Kogyo Kabushiki Kaisha 3-aminoindazole derivatives and process for preparation thereof
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US4717658A (en) * 1985-12-03 1988-01-05 Miles Inc. Gram negative bacteria screening method with horseshoe crab amebocyte lysate (LAL)
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
ES2076253T3 (es) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
CA2030051C (en) * 1989-11-17 2001-08-07 Haruhiko Kikuchi Indole derivatives

Also Published As

Publication number Publication date
EP0509402A1 (en) 1992-10-21
KR920019777A (ko) 1992-11-20
CA2066332A1 (en) 1992-10-18
RO109847B1 (ro) 1995-06-30
FI921693A7 (fi) 1992-10-18
NZ242359A (en) 1995-03-28
JP2617650B2 (ja) 1997-06-04
AU655253B2 (en) 1994-12-08
PL168905B1 (pl) 1996-05-31
IL101599A0 (en) 1992-12-30
IL101599A (en) 1996-05-14
CA2066332C (en) 2003-07-29
TW200477B (es) 1993-02-21
JPH05117266A (ja) 1993-05-14
KR100254027B1 (ko) 2000-05-01
DK0509402T3 (da) 1998-09-07
NO180486C (no) 1997-04-30
BG96202A (bg) 1993-12-24
BG61034B1 (bg) 1996-09-30
NO180486B (no) 1997-01-20
CS117192A3 (en) 1992-11-18
GR3026317T3 (en) 1998-06-30
NO921505D0 (no) 1992-04-15
AU1512192A (en) 1992-10-22
IE921235A1 (en) 1992-10-21
DE69223837D1 (de) 1998-02-12
US5177088A (en) 1993-01-05
RU2060254C1 (ru) 1996-05-20
FI105096B (fi) 2000-06-15
PL294239A1 (en) 1993-06-14
ZA922807B (en) 1992-11-25
ATE161840T1 (de) 1998-01-15
MX9201759A (es) 1992-10-01
EP0509402B1 (en) 1998-01-07
HUT62572A (en) 1993-05-28
HU215113B (hu) 1998-12-28
NO921505L (no) 1992-10-19
HU9201297D0 (en) 1992-07-28
FI921693A0 (fi) 1992-04-15
DE69223837T2 (de) 1998-06-25

Similar Documents

Publication Publication Date Title
ES2111580T3 (es) 3-(piridinilamino)-indoles y benzo(b)tiofenos sustituidos, un procedimiento para su preparacion y su uso como medicamentos.
MX9304996A (es) Heterociclos no-aromaticos que contienen bencilamino nitrogeno substituido.
ES2194314T3 (es) Derivados de benzopirano sustituidos para el tratamiento de inflamaciones.
CO4950558A1 (es) Moduladores de receptores de aminoacidos excitadores
ES2191005T3 (es) Taxanos sustituidos como agentes antitumorales.
ES2113368T3 (es) Antagonistas de serotonina.
ES2037208T3 (es) Un metodo para preparar derivados 3-aminometilicos de indano, indolina, dihidrobenzofurano y dihidrobenzotiofeno.
ES2109239T3 (es) 5-(1-aminociclohexil)-2(1h)-piridinona y compuestos relacionados.
DE69406594D1 (de) Hydrierung von aromatischen Aminen zur Herstellung der entsprechenden ringhydrierten Verbindungen
MX9605218A (es) Amidas aciclicas y ciclicas novedosas como mejoradores de liberacion de neurotransmisores.
ES2089204T3 (es) Compuestos de quinoxalina y su preparacion y uso.
ES2060709T3 (es) Derivados de piridilo y pirimidilo.
AR034585A1 (es) Nuevos compuestos de dihidropirimidina ciano substituidos y su uso para tratar padecimientos
ES2062758T3 (es) Nuevos analogos de vitamina d.
MX9202736A (es) [(arilalquilpiperidin-4-il)metil)]-2a,3,4,5,-tetrahidro-1(2h)-acenafti len-1-onas y compuestos afines, un procedimiento para su preparacion y su empleo como medicamentos.
ES2085940T3 (es) 4-amino-3-piridinoles sustituidos, un procedimiento para su preparacion y su uso como medicamentos.
DE69218042D1 (de) Aromatische Amid-Verbindungen und ihre Herstellung und Anwendung
ES2111025T3 (es) Piridinilamino-1h-indoles, 1h-indazoles, 2h-indazoles, benzo(b)tiofenos y 1,2-benzoisotiazoles sustituidos, un procedimiento para su preparacion y su utilizacion como medicamentos.
CO4600635A1 (es) Procedimientos e intermedios para preparar derivados de cromanol sustituidos
ES2121761T3 (es) Carbamatos sustituidos de 1-(piridinilamino sustituido)-1h-indol-5-ilo, un procedimiento para su preparacion y su uso como medicamentos.
AR013152A1 (es) Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n.
DE69021347D1 (de) Isatinderivate, ihre Herstellung und Verwendung.
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
ES2061680T3 (es) Acidos y esteres azetidinilquinolonacarboxilicos.
ATE109136T1 (de) Substituierte cyclohexene mit zentraler nervensystem-wirkung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509402

Country of ref document: ES